(S1 (S (S (NP (NN PTEN)) (VP (VBZ represses) (NP (NN RNA) (NN polymerase) (JJ III-dependent) (NN transcription)) (PP (IN by) (S (VP (VBG targeting) (NP (DT the) (NN TFIIIB) (NN complex))))))) (. .)))
(S1 (S (S (NP (NP (NN PTEN)) (, ,) (NP (NP (DT a) (NN tumor) (NN suppressor)) (SBAR (WHNP (WP$ whose) (NN function)) (S (VP (VBZ is) (ADVP (RB frequently)) (VP (VBN lost) (PP (IN in) (NP (JJ human) (NNS cancers)))))))) (, ,)) (VP (VBZ possesses) (NP (NP (DT a) (NN lipid) (NN phosphatase) (NN activity)) (SBAR (WHNP (WDT that)) (S (VP (VBZ represses) (NP (NP (NP (NN phosphatidylinositol) (NN 3-kinase)) (PRN (-LRB- -LRB-) (NP (NN PI3K)) (-RRB- -RRB-))) (NN signaling)) (, ,) (S (VP (VBG controlling) (NP (NN cell) (NP (NP (NN growth)) (, ,) (NP (NN proliferation)) (, ,) (CC and) (NP (NN survival)))))))))))) (. .)))
(S1 (S (S (NP (NP (DT The) (NN potential)) (PP (IN for) (NP (NN PTEN))) (S (VP (TO to) (VP (VB regulate) (NP (NP (DT the) (NN synthesis)) (PP (IN of) (NP (NP (NP (NN RNA) (NN polymerase) (-LRB- -LRB-) (NN Pol) (-RRB- -RRB-) (CD III)) (NN transcription) (NNS products)) (, ,) (PP (VBG including) (NP (NP (NNS tRNAs)) (CC and) (NP (NN 5S) (NNS rRNAs)))) (, ,)))))))) (VP (VBD was) (VP (VBN evaluated)))) (. .)))
(S1 (S (S (NP (NP (DT The) (NN expression)) (PP (IN of) (NP (NN PTEN))) (PP (IN in) (NP (JJ PTEN-deficient) (NNS cells)))) (VP (VBD repressed) (NP (NN RNA) (NN Pol) (CD III) (NN transcription)) (, ,) (SBAR (IN whereas) (S (NP (VBN decreased) (NN PTEN) (NN expression)) (VP (VBD enhanced) (NP (NN transcription))))))) (. .)))
(S1 (S (S (NP (NP (NN Transcription) (NN repression)) (PP (IN by) (NP (NN PTEN)))) (VP (VP (VBD was) (VP (VBD uncoupled) (PP (IN from) (NP (NP (JJ PTEN-mediated) (NNS effects)) (PP (IN on) (NP (DT the) (NN cell) (NN cycle))))))) (CC and) (VP (VBD was) (ADJP (JJ independent) (PP (IN of) (NP (NN p53))))))) (. .)))
(S1 (S (S (NP (NN PTEN)) (VP (VBZ acts) (PP (IN through) (NP (PRP$ its) (NN lipid) (NN phosphatase) (NN activity))) (, ,) (S (VP (VBG inhibiting) (NP (NP (DT the) (NN PI3K/Akt/mTOR/S6K) (NN pathway)) (S (VP (TO to) (VP (VB decrease) (NP (NN transcription)))))))))) (. .)))
(S1 (S (S (NP (NP (NN PTEN)) (, ,) (PP (IN through) (NP (NP (DT the) (NN inactivation)) (PP (IN of) (NP (NN mTOR))))) (, ,)) (VP (VBZ targets) (NP (DT the) (NN TFIIIB) (NN complex)) (, ,) (S (VP (VBG disrupting) (NP (NP (DT the) (NN association)) (PP (IN between) (NP (NP (JJ TATA-binding) (NN protein)) (CC and) (NP (NN Brf1))))))))) (. .)))
(S1 (S (S (NP (JJ Kinetic) (NN analysis)) (VP (VBD revealed) (SBAR (IN that) (S (NP (NN PTEN)) (ADVP (RB initially)) (VP (VBZ induces) (NP (NP (DT a) (NN decrease)) (PP (IN in) (NP (NP (DT the) (NN serine) (NN phosphorylation)) (PP (IN of) (NP (NN Brf1)))))) (, ,) (S (VP (VBG leading) (PP (TO to) (NP (NP (DT a) (JJ selective) (NN reduction)) (PP (IN in) (NP (NP (DT the) (NN occupancy)) (PP (IN of) (NP (DT all) (NN TFIIIB) (NNS subunits))) (PP (IN on) (NP (JJ tRNA-LRB-Leu-RRB-) (NNS genes))))))))) (, ,) (SBAR (IN whereas) (S (NP (JJ prolonged) (NN PTEN) (NN expression)) (VP (VBZ results) (PP (IN in) (NP (NP (DT the) (VBN enhanced) (NN serine) (NN phosphorylation)) (PP (IN of) (NP (NN Bdp1))))))))))))) (. .)))
(S1 (S (S (ADVP (RB Together)) (, ,) (NP (DT these) (NNS results)) (VP (VBP demonstrate) (NP (NP (DT a) (JJ new) (NN class)) (PP (IN of) (NP (NP (NNS genes)) (VP (VBN regulated) (PP (IN by) (NP (NN PTEN))) (PP (IN through) (NP (PRP$ its) (NN ability) (S (VP (TO to) (VP (VB repress) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NN PI3K/Akt/mTOR/S6K) (NN signaling))))))))))))))) (. .)))
